Anavex Life Sciences Corp (AVXL)

[kevli33]

Anavex Life Sciences to Announce Fiscal Third Quarter 2018 Financial Results on Thursday, August 9, 2018


Conference Call and Webcast To be Held Thursday, August 9, 2018 at 4:30pm Eastern time


NEW YORK, NY – August 7, 2018 – Anavex Life Sciences Corp., (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Rett Syndrome and other central nervous system (CNS) diseases, today announced that it will issue financial results for the Fiscal Third Quarter ended June 30, 2018 on Thursday, August 9, 2018.

Management will host a conference call on Thursday, August 9, 2018 at 4:30pm Eastern Time to review financial results and provide an update on its clinical programs and corporate highlights. Following management’s formal remarks, there will be a question and answer session.

Conference Call / Webcast Information

To listen to the live call by phone, interested parties within the U.S. should dial, toll-free, 1 [phone] and international callers should dial 1 [phone]. Please use confirmation number 47394949, followed by the pound sign (#). The conference call will also be available through a live webcast at http://www.wsw.com/webcast/cc/avxl6/.


A replay of the call will be available approximately one hour after the end of the call through September 9, 2018 at www.anavex.com.